Iron replacement therapy

6 marketed 3 in Phase 3 1 in Phase 2

This page covers all Iron replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Iron (Fe3+) delivery to erythropoietic tissues, Iron metabolism pathway; ferric iron (Fe3+).

Targets

Iron (Fe3+) delivery to erythropoietic tissues · Iron metabolism pathway; ferric iron (Fe3+)

Marketed (6)

Phase 3 pipeline (3)

Phase 2 pipeline (1)